2.45 USD
↘ 0.04 (1.61%)AT CLOSE (11:59 AM EDT)
Atossa Therapeutics, Inc. Common Stock
ATOSNASDAQ • USD
2.48
↗ 0.03 (1.22%)
POST MARKET (AS OF 06:28 PM EDT)
Post Market
AS OF 06:28 PM EDT
2.48
↗ 0.03 (1.22%)
Market: OPEN
ATOS is currently priced at $2.48. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Jul 8, 2026.
Open?$2.51
High?$2.54
Low?$2.38
Prev. Close?$2.49
Volume?128.0K
Avg. Volume?245.6K
VWAP?$2.44
Rel. Volume?0.52x
Bid / Ask
Bid?$2.07 × 100
Ask?$2.84 × 100
Spread?$0.77
Midpoint?$2.46
Valuation & Ratios
Market Cap?24.8M
Shares Out?8.6M
Float?7.7M
Float %?89.2%
P/E Ratio?N/A
P/B Ratio?0.81
EPS?-$3.77
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.
Themes
Employees
14
Market Cap
22.7M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2012-11-08
Address
1448 NW MARKET STREET
SEATTLE, WA 98107
Phone: 206.588.0256
SEATTLE, WA 98107
Phone: 206.588.0256
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?45
Piotroski F-Score?0/9Weak
Altman Z-Score?-9.98Distress
Confidence?51%Low
Short InterestElevated
Short % of Float?6.95%Elevated
Short Interest?533.3K
Days to Cover?2.0
Free Float7.7M
Avg Daily Volume262.4K
Settlement Date2026-06-15
Financial Health
Current Ratio?4.90Strong
Quick Ratio?4.50Strong
Cash Ratio?4.25Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.81CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.2CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-123.5%WEAK▾
S&P3
ROA?-99.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-33398000
Enterprise Value?$-6880257
Fundamentals ratios updated end of day